AGENUS INC
AGEN · NASDAQ
Updated at 2026-10-14 09:03:13
- Today's High
- $7.34
- Today’s Low
- $6.80
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $7.62
- Previous Close
- $7.43
- Volume
- 572.49K
- Market Cap
- $335.55M
- P/E Ratio
- 3.76X
- EPS
- $2.64
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3 FORBES ROAD, LEXINGTON, MA, UNITED STATES, 02421-7305
- Country
- US
- Listing Date
- 2000-02-04
- Fiscal Year End
- December
- Shares Outstanding
- 41.64M
- CIK
- 0001098972
- Website
- agenusbio.com
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$34.51M
2026-03-31
$33.73M
2025-12-31
$34.2M
2025-09-30
$30.23M
Operating Expenses
2026-06-30
$23.22M
2026-03-31
$18.68M
2025-12-31
$19.8M
2025-09-30
$34.13M
Net Income
2026-06-30
-$550K
2026-03-31
$39.22M
2025-12-31
-$10.57M
2025-09-30
$63.91M
Net Profit Margin
2026-06-30
-1.59%
2026-03-31
116.27%
2025-12-31
-30.92%
2025-09-30
211.39%
Earnings Per Share
2026-06-30
$-0.01
2026-03-31
$-0.03
2025-12-31
$0.68
2025-09-30
$-1.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$15.19M
2026-03-31
$54.45M
2025-12-31
$6M
2025-09-30
$80.11M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $34.51M | $33.73M | $34.2M | $30.23M |
| Operating Expenses | $23.22M | $18.68M | $19.8M | $34.13M |
| Net Income | -$550K | $39.22M | -$10.57M | $63.91M |
| Net Profit Margin | -1.59% | 116.27% | -30.92% | 211.39% |
| Earnings Per Share | $-0.01 | $-0.03 | $0.68 | $-1.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $15.19M | $54.45M | $6M | $80.11M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.